Health · Medical Research · 6 hrs ago
Families face lasting burdens during children's B-cell leukemia treatment
A study tracked family impacts of B-cell acute lymphoblastic leukemia in children receiving treatment.
It included 420 patients aged 4 and older with standard- or average-risk disease, assigned to maintenance treatment every four or 12 weeks.
Parents reported changes at home and other strains through surveys taken over about three years.
By about 26 months after diagnosis, 81.2% reported changes at home, 23.9% reported unhealthy family functioning, and 62.5% saw their child as vulnerable.
Most family outcomes were similar across treatment schedules, though families in the four-week group were more likely to report at least $100 in leukemia-related household expenses over four weeks.
The findings point to a need for family support regardless of treatment intensity.
A study found that families of children with B-cell acute lymphoblastic leukemia reported burdens during treatment, including household changes, expenses and concerns about the child’s vulnerability.
The study involved 420 patients aged 4 and older with standard- or average-risk disease who were randomly assigned to one of two maintenance treatment schedules.
At about two months after diagnosis, 56.2% of participants reported household changes and 88.6% reported at least $100 in leukemia-related household expenses in the previous four weeks.
By about 26 months, 81.2% reported household changes, while 61.5% reported at least $100 in recent expenses.
The researchers said most adverse family outcomes did not differ between the treatment groups, highlighting the need for family support regardless of treatment intensity.
- Who
- Families of children aged 4 and older with standard- or average-risk B-cell acute lymphoblastic leukemia.
- What
- A study examined adverse family outcomes during treatment. It found that most outcomes were similar between two treatment schedule groups.
- When
- The study was published online on October 13, 2026. Surveys were conducted about 2, 9, 18, 26 and 38 months after diagnosis.
- Where
- Not stated
- Why
- The study examined family outcomes and whether they differed by maintenance treatment schedule.
This story does not have two clearly opposing sides.
At the first survey, 56.2% reported household changes and 88.6% reported at least $100 in leukemia-related household expenses in the previous four weeks.
At the fourth survey, 81.2% reported household changes and 61.5% reported at least $100 in recent leukemia-related household expenses.
The study was published online in the Journal of the National Comprehensive Cancer Network.
- Patients
- 420 randomly assigned
- Age
- 4 years and older
- Treatment schedules
- Vincristine/dexamethasone every 4 or 12 weeks
- First survey
- About 2 months after diagnosis
- Fourth survey
- About 26 months after diagnosis
- Recent expenses at first survey
- 88.6% reported at least $100 in leukemia-related household expenses in the previous four weeks
What people are saying
We expected this study to find that lower treatment intensity would lead to a reduction in adverse family outcomes, but for the most part that was not the case. This highlights the need for family support regardless of treatment intensity.